DK495781A - Fremgangsmaade til fremstilling af n-substituerede omega-(2-oxoimidazolin-1-yl) alkansyrer og salte og estere deraf - Google Patents

Fremgangsmaade til fremstilling af n-substituerede omega-(2-oxoimidazolin-1-yl) alkansyrer og salte og estere deraf

Info

Publication number
DK495781A
DK495781A DK495781A DK495781A DK495781A DK 495781 A DK495781 A DK 495781A DK 495781 A DK495781 A DK 495781A DK 495781 A DK495781 A DK 495781A DK 495781 A DK495781 A DK 495781A
Authority
DK
Denmark
Prior art keywords
esters
salts
oxoimidazolin
procedure
preparation
Prior art date
Application number
DK495781A
Other languages
English (en)
Inventor
H H Lautenschlaeger
H Betzing
B Stoll
M Probst
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of DK495781A publication Critical patent/DK495781A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK495781A 1980-11-11 1981-11-09 Fremgangsmaade til fremstilling af n-substituerede omega-(2-oxoimidazolin-1-yl) alkansyrer og salte og estere deraf DK495781A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803042466 DE3042466A1 (de) 1980-11-11 1980-11-11 N-substituierte (omega) -(2-oxo-4-imidazolin-l-yl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Publications (1)

Publication Number Publication Date
DK495781A true DK495781A (da) 1982-05-12

Family

ID=6116469

Family Applications (1)

Application Number Title Priority Date Filing Date
DK495781A DK495781A (da) 1980-11-11 1981-11-09 Fremgangsmaade til fremstilling af n-substituerede omega-(2-oxoimidazolin-1-yl) alkansyrer og salte og estere deraf

Country Status (9)

Country Link
US (1) US4349684A (da)
EP (1) EP0051829B1 (da)
JP (1) JPS57108073A (da)
AT (1) ATE10626T1 (da)
DE (1) DE3042466A1 (da)
DK (1) DK495781A (da)
GR (1) GR74703B (da)
IE (1) IE52079B1 (da)
ZA (1) ZA817696B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228271A1 (de) * 1982-07-29 1984-02-02 A. Nattermann & Cie GmbH, 5000 Köln Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3323870A1 (de) * 1983-07-02 1985-01-03 A. Nattermann & Cie GmbH, 5000 Köln Neue imidazol-2-ylthioalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4598149A (en) * 1984-03-02 1986-07-01 Merck & Co., Inc. 3-amino-2-hydroxypropyl of pyrimidin-4-one useful as antihypertensive, cardioprotective, antiarrythmic, and antianginal agents
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.
CA2014537A1 (en) * 1989-04-26 1990-10-26 Yoshio Hayashi 4-imidazoline derivatives
GB9019839D0 (en) * 1990-09-11 1990-10-24 Smith Kline French Lab Compounds
GB9019840D0 (en) * 1990-09-11 1990-10-24 Smith Kline French Lab Compounds
CA2085844A1 (en) * 1991-12-27 1993-06-28 Nobuyuki Hamanaka Fused benzeneoxyacetic acid derivatives
EP0757988A4 (en) * 1994-04-27 2000-07-26 Nippon Soda Co IMIDAZOLE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME
US6017926A (en) * 1997-12-17 2000-01-25 Merck & Co., Inc. Integrin receptor antagonists
EA003095B1 (ru) * 1997-12-17 2002-12-26 Мерк Энд Ко., Инк. Антагонисты рецепторов интегринов
WO2001024797A1 (en) * 1999-10-04 2001-04-12 Merck & Co., Inc. Integrin receptor antagonists
SE0100569D0 (sv) * 2001-02-20 2001-02-20 Astrazeneca Ab New compounds
JP5683787B2 (ja) 2005-08-18 2015-03-11 シンタ ファーマシューティカルズ コーポレーション Ｈｓｐ９０活性を調節するイミダゾール化合物
DE102006024024A1 (de) 2006-05-23 2007-11-29 Bayer Healthcare Aktiengesellschaft Substituierte Arylimidazolone und -triazolone sowie ihre Verwendung
DE102008060967A1 (de) 2008-12-06 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Substituierte Phenylsulfonyltriazolone und ihre Verwendung
DE102010001064A1 (de) 2009-03-18 2010-09-23 Bayer Schering Pharma Aktiengesellschaft Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung
MA34019B1 (fr) 2010-02-27 2013-02-01 Bayer Ip Gmbh Aryltriazolone liée à un bis-aryle et son utilisation
DE102010040187A1 (de) 2010-09-02 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Substituierte N-Phenethyl-triazolonacetamide und ihre Verwendung
DE102010040924A1 (de) 2010-09-16 2012-03-22 Bayer Schering Pharma Aktiengesellschaft Substituierte Phenylacet- und Phenylpropanamide und ihre Verwendung
ES2697902T3 (es) 2014-11-03 2019-01-29 Bayer Pharma AG Derivados de feniltriazol sustituido con hidroxialquilo y sus usos
US9988367B2 (en) 2016-05-03 2018-06-05 Bayer Pharma Aktiengesellschaft Amide-substituted pyridinyltriazole derivatives and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2194369B1 (da) * 1972-08-04 1980-04-25 Roussel Uclaf
DE2713431A1 (de) * 1977-03-26 1978-09-28 Bayer Ag Verfahren zur herstellung von diacylierten 4-imidazolinonen-2 und deren verwendung fuer cycloadditionen
DE2934746A1 (de) 1979-08-28 1981-03-19 A. Nattermann & Cie GmbH, 5000 Köln Oxoimidazolinalkansaeuren, deren salze und ester sowie verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2950478A1 (de) 1979-12-14 1981-06-19 A. Nattermann & Cie GmbH, 5000 Köln 4,5-diaryl-4-imidazolin-2-on-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
JPS57108073A (en) 1982-07-05
IE52079B1 (en) 1987-06-10
ZA817696B (en) 1982-10-27
DE3042466A1 (de) 1982-06-16
EP0051829A1 (en) 1982-05-19
EP0051829B1 (en) 1984-12-05
US4349684A (en) 1982-09-14
GR74703B (da) 1984-07-05
IE812565L (en) 1982-05-11
ATE10626T1 (de) 1984-12-15

Similar Documents

Publication Publication Date Title
DK495781A (da) Fremgangsmaade til fremstilling af n-substituerede omega-(2-oxoimidazolin-1-yl) alkansyrer og salte og estere deraf
SE7713721L (sv) Substituerade acylderivat av aminosyror
SE7906533L (sv) Pyrrolidinderivat
DK465879A (da) Fremgangsmaade til fremstilling af pyrimido-(6,1-a)isoquinolin-4-oner og hertil anvendelige mellemprodukter
DK505983A (da) Imidazolylalkylthienyl-tetrahydropyridaziner og fremgangsmaade til fremstilling deraf
DK33196A (da) Anvendelse af disubstituerede prolinderivater til fremstilling af tilsvarende carboxylsyrer og deres derivater
DK148183A (da) Fremgangsmaade til fremstilling af imidazolylphenyl-tetrahydropyridaziner
SE7608691L (sv) Forfarande for framstellning av tienopyridinderivat
DK495681A (da) Fremgangsmaade til fremstilling af n-benzoy1-omega-anilino-alkancarboxylsyrer og salte og estere deraf
NO158378C (no) Analogifremgangsmaate for fremstilling av halogenerte proteaseinhibitorer.
DK204686A (da) Quinolylglycinamidderivater og fremgangsmaade til fremstilling deraf
ES2059688T3 (es) Derivados de aminoacidos inhibidores de enzimas, procedimiento para su preparacion, agentes que los contienen y su utilizacion.
ES529223A0 (es) Un procedimiento de preparacion de imino-2-pirrolidinas.
DK358183A (da) Fremgangsmaade til fremstilling af alfa-aryl-alkansyrer eller salte deraf
SE7908168L (sv) Cysteinderivat
ES545009A0 (es) Procedimiento de preparacion de nuevas fenil-naftiridinas.
LV10234A (lv) Trijodbenzola savienojumu iegusanas metode
DK12584A (da) Bicyclo(4.2.0)1,3,5-octatrienderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende disse
ES524040A0 (es) Procedimiento para la preparacion de cefalosporinas
DK484684D0 (da) Derivater af 4-alkyl-2-hydroxy-3-methyl-2-phenylmorpholin, fremgangsmaade til deres fremstilling og deres terapeutiske anvendelse
DK0427125T3 (da) Benzylselenobenzamider af aniliner og benzylaminer
DK0397048T3 (da) Fremgangsmåde til fremstilling af 2-mercapto-4-methyl-1,3-thiazol-5-yl-eddikesyre og dens estere
SE8401280L (sv) Mellanprodukter och forfaraden for framstellning derav
MX6943E (es) Procedimiento para preparar ureidobencilpenicilinas alfa-substituidas
DK0427160T3 (da) Benzylselenobenzamid af aminopyridiner og picolylaminer

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment